Amedeo Smart

Free Medical Literature Service

 

Amedeo

Parkinson's Disease
  Free Subscription

Articles published in
Ann Neurol
    April 2024
  1. GONZALEZ-LATAPI P, Bustos B, Dong S, Lubbe S, et al
    Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's Disease.
    Ann Neurol. 2024 Apr 2. doi: 10.1002/ana.26923.
    >> Share

  2. POST E, Hall DA, Bloem BR
    Reply to "An Apple a Day Will Not Keep the (Parkinson's Disease) Doctor at Bay!".
    Ann Neurol. 2024 Apr 1. doi: 10.1002/ana.26937.
    >> Share

  3. KHANI M, Cerquera-Cleves C, Kekenadze M, Wild Crea P, et al
    Towards a Global View of Parkinson's Disease Genetics.
    Ann Neurol. 2024 Apr 1. doi: 10.1002/ana.26905.
    >> Share

  4. SAKOWSKI SA, Koubek EJ, Chen KS, Goutman SA, et al
    Role of the Exposome in Neurodegenerative Disease: Recent Insights and Future Directions.
    Ann Neurol. 2024;95:635-652.
    >> Share

    March 2024
  5. BOOGERS A, Fasano A, Lang A
    An Apple a Day Will Not Keep the (Parkinson Disease) Doctor at Bay!
    Ann Neurol. 2024 Mar 30. doi: 10.1002/ana.26936.
    >> Share

  6. KLUGE A, Borsche M, Streubel-Gallasch L, Gul T, et al
    alpha-Synuclein Pathology in PRKN-Linked Parkinson's Disease: New Insights from a Blood-Based Seed Amplification Assay.
    Ann Neurol. 2024 Mar 28. doi: 10.1002/ana.26917.
    >> Share

  7. DEL BENE VA, Martin RC, Brinkerhoff SA, Olson JW, et al
    Differential Cognitive Effects of Unilateral Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease.
    Ann Neurol. 2024 Mar 19. doi: 10.1002/ana.26903.
    >> Share

    December 2023
  8. WIESMAN AI, da Silva Castanheira J, Fon EA, Baillet S, et al
    Alterations of cortical structure and neurophysiology in Parkinson's disease are aligned with neurochemical systems.
    Ann Neurol. 2023 Dec 26. doi: 10.1002/ana.26871.
    >> Share

  9. REYNOSO A, Torricelli R, Jacobs BM, Shi J, et al
    Gene-environment interactions for Parkinson's disease.
    Ann Neurol. 2023 Dec 19. doi: 10.1002/ana.26852.
    >> Share

    November 2023
  10. ZHOU L, Li SX, Chau SW, Huang B, et al
    Altered impulsivity across drug-naive parkinsonism, isolated REM sleep behavior disorder, and their high-risk relatives.
    Ann Neurol. 2023 Nov 23. doi: 10.1002/ana.26836.
    >> Share

  11. CHUN MY, Chung SJ, Kim SH, Park CW, et al
    Hippocampal Perfusion Affects Motor and Cognitive Functions in Parkinson's Disease: An Early-Phase (18) F-FP-CIT PET Study.
    Ann Neurol. 2023 Nov 14. doi: 10.1002/ana.26827.
    >> Share

    August 2023
  12. MOHAMMADZADEH N, Tung GA, Prakash P, Alhusaini S, et al
    Parkinsonism: A Rare Complication of Cerebral Toxoplasmosis.
    Ann Neurol. 2023 Aug 30. doi: 10.1002/ana.26777.
    >> Share

  13. KANG X, Ploner A, Roelstraete B, Ludvigsson JF, et al
    Risk of Parkinson's disease in celiac disease: A Swedish population-based study.
    Ann Neurol. 2023 Aug 26. doi: 10.1002/ana.26780.
    >> Share

    June 2023
  14. HE P, Shi L, Li Y, Duan Q, et al
    The Association of the Glymphatic Function with Parkinson's Disease Symptoms: Neuroimaging Evidence from Longitudinal and Cross-sectional Studies.
    Ann Neurol. 2023 Jun 28. doi: 10.1002/ana.26729.
    >> Share

  15. NIETHAMMER M, Tang CC, Jamora RDG, Vo A, et al
    A network imaging biomarker of X-linked dystonia-parkinsonism.
    Ann Neurol. 2023 Jun 27. doi: 10.1002/ana.26732.
    >> Share

  16. PALACIOS N, Wilkinson J, Bjornevik K, Schwarzschild MA, et al
    Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes.
    Ann Neurol. 2023 Jun 14. doi: 10.1002/ana.26719.
    >> Share

    May 2023
  17. HACKER ML, Rajamani N, Neudorfer C, Hollunder B, et al
    Connectivity Profile for Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease.
    Ann Neurol. 2023 May 13. doi: 10.1002/ana.26674.
    >> Share

  18. WILKINS KB, Kehnemouyi YM, Petrucci MN, Anderson RW, et al
    Bradykinesia and Its Progression Are Related to Interhemispheric Beta Coherence.
    Ann Neurol. 2023;93:1029-1039.
    >> Share

    April 2023
  19. NEDELEC T, Couvy-Duchesne B, Darves-Bornoz A, Couronne R, et al
    A comparison between early presentation of dementia with Lewy Bodies, Alzheimer's disease and Parkinson's disease: evidence from routine primary care and UK Biobank data.
    Ann Neurol. 2023 Apr 25. doi: 10.1002/ana.26670.
    >> Share

    March 2023
  20. LIU B, Svenningsson P, Ludvigsson JF, Lundholm C, et al
    beta2-adrenoreceptor agonists, montelukast, and Parkinson's disease risk.
    Ann Neurol. 2023 Mar 10. doi: 10.1002/ana.26638.
    >> Share

  21. LANORE A, Casse F, Tesson C, Courtin T, et al
    Differences in survival across monogenic forms of Parkinson's disease.
    Ann Neurol. 2023 Mar 10. doi: 10.1002/ana.26636.
    >> Share

  22. TROPEA TF, Albuja I, Cousins KAQ, Irwin DJ, et al
    Concomitant Alzheimer's Disease Pathology in Parkinson's Disease Dementia.
    Ann Neurol. 2023 Mar 9. doi: 10.1002/ana.26635.
    >> Share

  23. YOUNCE JR, Martin WRW, Perlmutter JS
    Reply to "Concomitant Alzheimer's Disease Pathology in Parkinson's Disease Dementia".
    Ann Neurol. 2023 Mar 9. doi: 10.1002/ana.26630.
    >> Share

    February 2023
  24. JACOB MA, Cai M, Bergkamp M, Darweesh SKL, et al
    Cerebral Small Vessel Disease Progression Increases Risk of Incident Parkinsonism.
    Ann Neurol. 2023 Feb 10. doi: 10.1002/ana.26615.
    >> Share

  25. MIYAMOTO K, Saiki S, Matsumoto H, Suzuki A, et al
    Systemic Metabolic Alteration Dependent on the Thyroid-Liver Axis in Early PD.
    Ann Neurol. 2023;93:303-316.
    >> Share

    January 2023
  26. BLOEM BR, Post E, Hall D
    An Apple a day to keep the Parkinson's disease doctor away?
    Ann Neurol. 2023 Jan 27. doi: 10.1002/ana.26612.
    >> Share

  27. BILLINGSLEY KJ, Ding J, Alvarez Jerez P, Illarionova A, et al
    Genome-wide analysis of Structural Variants in Parkinson's Disease.
    Ann Neurol. 2023 Jan 25. doi: 10.1002/ana.26608.
    >> Share

  28. HANSSEN H, Diesta CCE, Heldmann M, Dy J, et al
    Basal Ganglia Atrophy as a Marker for Prodromal X-linked Dystonia-Parkinsonism.
    Ann Neurol. 2023 Jan 16. doi: 10.1002/ana.26606.
    >> Share

  29. RAY NJ, Kanel P, Bohnen NI
    Atrophy of the cholinergic basal forebrain can detect presynaptic cholinergic loss in Parkinson's disease.
    Ann Neurol. 2023 Jan 4. doi: 10.1002/ana.26596.
    >> Share

    November 2022
  30. DE BARTOLO MI, Vivacqua G, Belvisi D, Mancinelli R, et al
    A combined panel of salivary biomarkers in de novo Parkinson's Disease.
    Ann Neurol. 2022 Nov 16. doi: 10.1002/ana.26550.
    >> Share

  31. MARTIN WRW, Younce JR, Campbell MC, Racette BA, et al
    Neocortical Lewy body pathology parallels Parkinson's dementia, but not always.
    Ann Neurol. 2022 Nov 4. doi: 10.1002/ana.26542.
    >> Share

  32. GARRIDO A, Perez-Sisques L, Simonet C, Campoy-Campos G, et al
    Increased Phospho-AKT in Blood Cells from LRRK2 G2019S Mutation Carriers.
    Ann Neurol. 2022;92:888-894.
    >> Share

    October 2022
  33. SCHIRINZI T, Maftei D, Passali FM, Grillo P, et al
    Olfactory neuron Prokineticin-2 as a potential target in Parkinson's disease.
    Ann Neurol. 2022 Oct 11. doi: 10.1002/ana.26526.
    >> Share

  34. RASCHELLA F, Scafa S, Puiatti A, Martin Moraud E, et al
    Actigraphy enables home screening of REM behavior disorder in Parkinson disease.
    Ann Neurol. 2022 Oct 4. doi: 10.1002/ana.26517.
    >> Share

    September 2022
  35. FUNG WK, Cohn M, Lang AE, Fasano A, et al
    Precision vs. Personalized DBS for GBA-related Parkinson disease.
    Ann Neurol. 2022 Sep 2. doi: 10.1002/ana.26499.
    >> Share

    August 2022
  36. AL-MUBARAK B, Ahmed Nour M, Schumacher-Schuh A, Bandres-Ciga S, et al
    Globalizing research towards diverse representation in Alzheimer's and Parkinson's disease.
    Ann Neurol. 2022 Aug 24. doi: 10.1002/ana.26483.
    >> Share

  37. MARIN-LAHOZ J, Martinez-Horta S, Pagonabarraga J, Horta-Barba A, et al
    Predicting Impulse Control Disorders in Parkinson's disease through incentive biomarkers.
    Ann Neurol. 2022 Aug 19. doi: 10.1002/ana.26486.
    >> Share

  38. PERINAN MT, Brolin K, Bandres-Ciga S, Blauwendraat C, et al
    Effect modification between genes and environment, and Parkinson's disease risk.
    Ann Neurol. 2022 Aug 1. doi: 10.1002/ana.26467.
    >> Share

    July 2022
  39. KENT DM, Leung LY, Puttock EJ, Wang AY, et al
    Development of Parkinson's disease and its relationship with incidentally-discovered white matter disease and covert brain infarction in a real-world cohort.
    Ann Neurol. 2022 Jul 22. doi: 10.1002/ana.26458.
    >> Share

  40. BOLLIRI C, Fontana A, Cereda E, Barichella M, et al
    Gut Microbiota in Monozygotic Twins Discordant for Parkinson's Disease.
    Ann Neurol. 2022 Jul 19. doi: 10.1002/ana.26454.
    >> Share

    June 2022
  41. PRANGE S, Lin Z, Nourredine M, Danaila T, et al
    Limbic stimulation drives mania in STN-DBS in Parkinson disease: a prospective study.
    Ann Neurol. 2022 Jun 15. doi: 10.1002/ana.26434.
    >> Share

  42. PAL G, Mangone G, Ouyang B, Ehrlich D, et al
    Reply to: Cognitive effects of deep brain stimulation in GBA-related Parkinson's disease.
    Ann Neurol. 2022 Jun 10. doi: 10.1002/ana.26433.
    >> Share

  43. WEILL C, Gallant A, Lintsky E, Dienstag A, et al
    Cognitive effects of deep brain stimulation in GBA-related Parkinson's disease.
    Ann Neurol. 2022 Jun 10. doi: 10.1002/ana.26432.
    >> Share

    May 2022
  44. LIU H, Dehestani M, Blauwendraat C, Makarious MB, et al
    Polygenic resilience modulates the penetrance of Parkinson's disease genetic risk factors.
    Ann Neurol. 2022 May 22. doi: 10.1002/ana.26416.
    >> Share

  45. HUANG Y, Liu Z, Li N, Tian C, et al
    Parkinson's disease derived exosomes aggravate neuropathology in SNCA*A53T mice.
    Ann Neurol. 2022 May 21. doi: 10.1002/ana.26421.
    >> Share

  46. SHEN J, Amari N, Zack R, Skrinak RT, et al
    Plasma MIA, CRP, and albumin predict cognitive decline in Parkinson's Disease.
    Ann Neurol. 2022 May 20. doi: 10.1002/ana.26410.
    >> Share

    April 2022
  47. CRAMER SW, Do TH, Palzer EF, Naik A, et al
    Persistent racial disparities in deep brain stimulation for Parkinson's disease.
    Ann Neurol. 2022 Apr 19. doi: 10.1002/ana.26378.
    >> Share

  48. FURUKAWA K, Shima A, Kambe D, Nishida A, et al
    Motor progression and nigrostriatal neurodegeneration in Parkinson's disease.
    Ann Neurol. 2022 Apr 15. doi: 10.1002/ana.26373.
    >> Share

    February 2022
  49. MONTENEGRO P, Pueyo M, Lorenzo JN, Villar MD, et al
    A secretory vesicle failure in Parkinson's disease occurs in human platelets.
    Ann Neurol. 2022 Feb 28. doi: 10.1002/ana.26335.
    >> Share

    January 2022
  50. TOSSERAMS A, Weerdesteyn V, Bal T, Bloem BR, et al
    Cortical correlates of gait compensation strategies in Parkinson's disease.
    Ann Neurol. 2022 Jan 24. doi: 10.1002/ana.26306.
    >> Share

  51. PAL G, Mangone G, Hill EJ, Ouyang B, et al
    Parkinson disease and STN-DBS: cognitive effects in GBA mutation carriers.
    Ann Neurol. 2022 Jan 4. doi: 10.1002/ana.26302.
    >> Share

    December 2021
  52. JOHANSSON ME, Cameron IGM, van der Kolk NM, De Vries NM, et al
    Aerobic exercise alters brain function and structure in Parkinson's disease a randomized controlled trial.
    Ann Neurol. 2021 Dec 24. doi: 10.1002/ana.26291.
    >> Share

    November 2021
  53. VILLANUEVA EB, Tresse E, Liu Y, Duarte JN, et al
    Neuronal TNFalpha, Not alpha-Syn, Underlies PDD-Like Disease Progression in IFNbeta-KO Mice.
    Ann Neurol. 2021;90:789-807.
    >> Share

    August 2021
  54. ZHANG C, Lai Y, Li J, He N, et al
    Subthalamic and pallidal stimulations in patients with Parkinson's disease: common and dissociable connections.
    Ann Neurol. 2021 Aug 14. doi: 10.1002/ana.26199.
    >> Share

  55. VERGER A, Grimaldi S, Ribeiro MJ, Frismand S, et al
    SPECT/PET molecular imaging for parkinsonism: a fast-developing field.
    Ann Neurol. 2021 Aug 2. doi: 10.1002/ana.26187.
    >> Share

    July 2021
  56. TAN EK
    Genetic studies of Parkinson's & Alzheimer's disease in Latinos/Hispanics: New Insights & Challenges.
    Ann Neurol. 2021 Jul 26. doi: 10.1002/ana.26179.
    >> Share

  57. WEISS D, Volkmann J, Fasano A, Kuhn A, et al
    Neurology Grand Rounds: Changing gears - DBS for dopaminergic desensitization in Parkinson's disease?
    Ann Neurol. 2021 Jul 7. doi: 10.1002/ana.26164.
    >> Share

  58. LOESCH DP, Horimoto ARVR, Heilbron K, Sarihan EI, et al
    Characterizing the Genetic Architecture of Parkinson's Disease in Latinos.
    Ann Neurol. 2021 Jul 6. doi: 10.1002/ana.26153.
    >> Share

    June 2021
  59. DARVISH H, Azcona LJ, Taghavi S, Firouzabadi SG, et al
    ANXA1 with anti-inflammatory properties might contribute to parkinsonism.
    Ann Neurol. 2021 Jun 28. doi: 10.1002/ana.26148.
    >> Share

  60. SINGER W, Schmeichel AM, Shahnawaz M, Schmelzer JD, et al
    Alpha-Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure.
    Ann Neurol. 2021;89:1212-1220.
    >> Share

    May 2021
  61. HEINZEL S, Aho VTE, Suenkel U, von Thaler AK, et al
    Gut microbiome signatures of risk and prodromal markers of Parkinson's disease.
    Ann Neurol. 2021 May 22. doi: 10.1002/ana.26128.
    >> Share

  62. ALBIN RL, Muller MLTM, Bohnen NI, Spino C, et al
    alpha4beta2(*) Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait-Balance Disorders.
    Ann Neurol. 2021 May 11. doi: 10.1002/ana.26102.
    >> Share

  63. LAI D, Alipanahi B, Fontanillas P, Schwantes-An TH, et al
    Genome-wide association studies of LRRK2 modifiers of Parkinson's disease.
    Ann Neurol. 2021 May 2. doi: 10.1002/ana.26094.
    >> Share

  64. KLEIN C, Konig IR
    Exploring uncharted territory: genetically determined sex differences in Parkinson's disease.
    Ann Neurol. 2021 May 2. doi: 10.1002/ana.26091.
    >> Share

    April 2021
  65. BLAUWENDRAAT C, Iwaki H, Makarious MB, Bandres-Ciga S, et al
    Investigation of Autosomal Genetic Sex Differences in Parkinson's disease.
    Ann Neurol. 2021 Apr 26. doi: 10.1002/ana.26090.
    >> Share

  66. RUSZ J, Hlavnicka J, Novotny M, Tykalova T, et al
    Speech biomarkers in rapid eye movement sleep behaviour disorder and Parkinson's disease.
    Ann Neurol. 2021 Apr 15. doi: 10.1002/ana.26085.
    >> Share

    March 2021
  67. ROSEBRAUGH M, Voight EA, Moussa EM, Jameel F, et al
    Foslevodopa/foscarbidopa: a new subcutaneous treatment for Parkinson's disease.
    Ann Neurol. 2021 Mar 26. doi: 10.1002/ana.26073.
    >> Share

  68. ELIAS GJB, Boutet A, Joel SE, Germann J, et al
    Probabilistic Mapping of Deep Brain Stimulation: Insights from 15 Years of Therapy.
    Ann Neurol. 2021;89:426-443.
    >> Share

    February 2021
  69. LE GUEN Y, Napolioni V, Belloy ME, Yu E, et al
    Common X-chromosome variants are associated with Parkinson's disease risk.
    Ann Neurol. 2021 Feb 14. doi: 10.1002/ana.26051.
    >> Share

  70. JENSEN MP, Jacobs BM, Dobson R, Bandres-Ciga S, et al
    Lower lymphocyte count is associated with increased risk of Parkinson's disease.
    Ann Neurol. 2021 Feb 2. doi: 10.1002/ana.26034.
    >> Share

  71. RAHAYEL S, Postuma RB, Montplaisir J, Misic B, et al
    A Prodromal Brain-Clinical Pattern of Cognition in Synucleinopathies.
    Ann Neurol. 2021;89:341-357.
    >> Share

  72. STANG CD, Mullan AF, Hajeb M, Camerucci E, et al
    Timeline of Rapid Eye Movement Sleep Behavior Disorder in Overt Alpha-Synucleinopathies.
    Ann Neurol. 2021;89:293-303.
    >> Share

    January 2021
  73. ANDERSEN MS, Bandres-Ciga S, Reynolds RH, Hardy J, et al
    Heritability enrichment implicates microglia in Parkinson's disease pathogenesis.
    Ann Neurol. 2021 Jan 27. doi: 10.1002/ana.26032.
    >> Share

    December 2020
  74. YAU WY, Sullivan R, Rocca C, Cali E, et al
    NOTCH2NLC Intermediate-length Repeat Expansion and Parkinson's Disease in Patients of European Descent.
    Ann Neurol. 2020 Dec 30. doi: 10.1002/ana.26003.
    >> Share

  75. SHI CH, Fan Y, Xu YM
    Reply to "NOTCH2NLC Intermediate-length Repeat Expansion and Parkinson's Disease".
    Ann Neurol. 2020 Dec 30. doi: 10.1002/ana.26005.
    >> Share

  76. CAVALLIERI F, Fraix V, Bove F, Mulas D, et al
    Predictors of long-term outcome of subthalamic stimulation in Parkinson disease.
    Ann Neurol. 2020 Dec 21. doi: 10.1002/ana.25994.
    >> Share

  77. TAN AH, Chong CW, Lim SY, Yap IKS, et al
    Gut microbial ecosystem in Parkinson's disease: New clinico-biological insights from multi-omics.
    Ann Neurol. 2020 Dec 3. doi: 10.1002/ana.25982.
    >> Share

  78. SHEN L, Jiang C, Hubbard CS, Ren J, et al
    Subthalamic Nucleus Deep Brain Stimulation Modulates 2 Distinct Neurocircuits.
    Ann Neurol. 2020;88:1178-1193.
    >> Share

    November 2020
  79. LEE JY, Ahn J, Shin J, Jeon B, et al
    Parafovea change and dopamine loss in the retina with Parkinson's disease.
    Ann Neurol. 2020 Nov 24. doi: 10.1002/ana.25972.
    >> Share

    October 2020
  80. KIM CY, Wirth T, Hubsch C, Nemeth AH, et al
    Reply to "PPP2R5D genetic mutations and early-onset parkinsonism".
    Ann Neurol. 2020 Oct 24. doi: 10.1002/ana.25945.
    >> Share

  81. MURUETA-GOYENA A, Del Pino R, Galdos M, Arana B, et al
    Retinal thickness predicts the risk of cognitive decline in Parkinson's disease.
    Ann Neurol. 2020 Oct 24. doi: 10.1002/ana.25944.
    >> Share

  82. DULOVIC-MAHLOW M, Konig IR, Trinh J, Diaw SH, et al
    Discordant monozygotic Parkinson disease twins: Role of mitochondrial integrity.
    Ann Neurol. 2020 Oct 23. doi: 10.1002/ana.25942.
    >> Share

  83. WALKER IM, Riboldi GM, Drummond P, Saade-Lemus S, et al
    PPP2R5D genetic mutations and early-onset parkinsonism.
    Ann Neurol. 2020 Oct 23. doi: 10.1002/ana.25943.
    >> Share

  84. ESPAY AJ, Marsili L, Mahajan A, Sturchio A, et al
    Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension.
    Ann Neurol. 2020 Oct 5. doi: 10.1002/ana.25923.
    >> Share

  85. SHI CH, Fan Y, Yang J, Yuan YP, et al
    NOTCH2NLC Intermediate-length Repeat Expansions are Associated with Parkinson's Disease.
    Ann Neurol. 2020 Oct 5. doi: 10.1002/ana.25925.
    >> Share

  86. LESAGE S, Lunati A, Houot M, Romdhan SB, et al
    Characterization of Recessive Parkinson Disease in a Large Multicenter Study.
    Ann Neurol. 2020;88:843-850.
    >> Share

    September 2020
  87. NUBER S, Nam AY, Rajsombath MM, Cirka H, et al
    A stearoyl-CoA desaturase inhibitor prevents multiple Parkinson's disease-phenotypes in alpha-synuclein mice.
    Ann Neurol. 2020 Sep 29. doi: 10.1002/ana.25920.
    >> Share

  88. SINGER W, Schmeichel AM, Shahnawaz M, Schmelzer JD, et al
    Alpha-Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies.
    Ann Neurol. 2020;88:503-512.
    >> Share

    June 2020
  89. IRMEN F, Horn A, Mosley P, Perry A, et al
    Left Prefrontal Connectivity Links Subthalamic Stimulation with Depressive Symptoms.
    Ann Neurol. 2020;87:962-975.
    >> Share

  90. MONZON-SANDOVAL J, Poggiolini I, Ilmer T, Wade-Martins R, et al
    Human-Specific Transcriptome of Ventral and Dorsal Midbrain Dopamine Neurons.
    Ann Neurol. 2020;87:853-868.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016